News
Rural cancer patients report faster care than urban counterparts
- Author:
- Will Pass
Publish date: June 18, 2018
In contrast to previous studies, urban patients reported longer delays in care, scoring “Getting Care Quickly” 2.27 points lower than rural...
News
Metastatic lung cancer: Pembrolizumab plus chemo prolongs survival
- Author:
- Will Pass
Publish date: June 5, 2018
Overall survival at 12 months in NSCLC patients treated with pembrolizumab-combination therapy was 69.2%, compared with 49.4% in patients treated...
News
Checkpoint inhibitors well tolerated by NSCLC patients with preexisting autoimmune disease
- Author:
- Will Pass
Publish date: May 21, 2018
Flares during checkpoint inhibitor therapy were generally mild, and toxicity rates were only slightly increased in NSCLC patients with AID.